Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dapagliflozin in Renal Transplant Allograft Dysfunction
NCT04743453Phase 4Completed
- Sponsor
- Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
- Start
- Aug 2021
- Primary completion
- Sep 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of dapagliflozin in allograft dysfunction, sponsored by Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo. Started Aug 2021; status: completed.
02
Drugs
dapagliflozin
03
Conditions
allograft dysfunction
Beyond the preview
Go deeper on NCT04743453.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04743453.